General Information of the Compound
| Compound ID |
CP0176681
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
6-bromo-5-methyl-2,3-dihydro-1H-indole-2,3-dione
Show/Hide
|
||||||||||||||||||
| Synonyms |
306325-13-3
6-BROMO-5-METHYLISATIN
6-bromo-5-methyl-1H-benzo[d]azolidine-2,3-dione
6-bromo-5-methyl-1H-indole-2,3-dione
6-bromo-5-methyl-2,3-dihydro-1H-indole-2,3-dione
6-bromo-5-methylindoline-2,3-dione
AC1LW5IO
AC1Q2O90
AKOS000484014
ALBB-012856
ARONIS016716
BBC/891
BDBM22838
CB09212
CBMicro_014209
CHEMBL221830
CTK7H5981
DQZFCBOXZKQQPM-UHFFFAOYSA-N
FCH1317267
Isatin-based compound, 58
KS-000049B7
MCULE-6005372434
MolPort-001-022-207
SBB071631
SCHEMBL5526009
SMSF0004612
STK042825
ZINC2052963
ZX-AN011645
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H6BrNO2
|
||||||||||||||||||
| Molecular Weight |
240.056
|
||||||||||||||||||
| Canonical SMILES |
Cc1cc2C(=O)C(=O)Nc2cc1Br
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H6BrNO2/c1-4-2-5-7(3-6(4)10)11-9(13)8(5)12/h2-3H,1H3,(H,11,12,13)
Show/Hide
|
||||||||||||||||||
| InChIKey |
DQZFCBOXZKQQPM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound